Baird Upgrades Regeneron Pharma (REGN) to Outperform, Sees Continued Upside On Strong Eylea Uptake
Go back to Baird Upgrades Regeneron Pharma (REGN) to Outperform, Sees Continued Upside On Strong Eylea Uptake| Regeneron (NASDAQ: REGN) | Delayed: 810.06 +6.58 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $803.48 | 52 Week High | $592.36 | |||
| Open | $801.76 | 52 Week Low | $325.35 | |||
| Day High | $813.18 | P/E | 212.61 | |||
| Day Low | $795.73 | EPS | $3.81 | |||
| Volume | 270,596 | |||||

